Organogenesis Holdings Inc (ORGO)
3.025
+0.74
(+32.68%)
USD |
NASDAQ |
May 10, 16:00
3.025
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Market Cap: 399.19M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 300.88M |
| May 08, 2024 | 304.84M |
| May 07, 2024 | 321.99M |
| May 06, 2024 | 315.39M |
| May 03, 2024 | 328.59M |
| May 02, 2024 | 328.59M |
| May 01, 2024 | 331.23M |
| April 30, 2024 | 310.11M |
| April 29, 2024 | 323.97M |
| April 26, 2024 | 310.11M |
| April 25, 2024 | 301.54M |
| April 24, 2024 | 393.25M |
| April 23, 2024 | 393.25M |
| April 22, 2024 | 391.93M |
| April 19, 2024 | 382.69M |
| April 18, 2024 | 377.41M |
| April 17, 2024 | 368.18M |
| April 16, 2024 | 377.41M |
| April 15, 2024 | 364.22M |
| April 12, 2024 | 380.05M |
| April 11, 2024 | 395.89M |
| April 10, 2024 | 389.29M |
| April 09, 2024 | 385.33M |
| April 08, 2024 | 391.93M |
| April 05, 2024 | 373.46M |
| Date | Value |
|---|---|
| April 04, 2024 | 369.50M |
| April 03, 2024 | 365.54M |
| April 02, 2024 | 344.42M |
| April 01, 2024 | 369.50M |
| March 28, 2024 | 374.78M |
| March 27, 2024 | 364.22M |
| March 26, 2024 | 345.74M |
| March 25, 2024 | 345.74M |
| March 22, 2024 | 344.42M |
| March 21, 2024 | 351.02M |
| March 20, 2024 | 369.50M |
| March 19, 2024 | 362.90M |
| March 18, 2024 | 362.90M |
| March 15, 2024 | 376.10M |
| March 14, 2024 | 374.78M |
| March 13, 2024 | 395.89M |
| March 12, 2024 | 387.97M |
| March 11, 2024 | 393.25M |
| March 08, 2024 | 410.41M |
| March 07, 2024 | 413.04M |
| March 06, 2024 | 376.10M |
| March 05, 2024 | 366.86M |
| March 04, 2024 | 380.05M |
| March 01, 2024 | 385.33M |
| February 29, 2024 | 471.11M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
247.92M
Minimum
Mar 24 2023
2.979B
Maximum
May 03 2021
782.62M
Average
504.26M
Median
Feb 12 2024
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.420M |
| Palatin Technologies Inc | 36.63M |
| iBio Inc | 6.516M |
| Theriva Biologics Inc | 6.002M |
| Oragenics Inc | 8.245M |
Market Cap Related Metrics
| PE Ratio | 84.83 |
| PS Ratio | 0.9257 |
| Price to Book Value | 1.432 |
| Price to Free Cash Flow | 61.19 |
| Price | 3.025 |
| Earnings Yield | 1.18% |
| Operating PE Ratio | 32.01 |
| Normalized PE Ratio | 84.83 |